Systematic review and meta-analysis of studies assessing the relationship between statin use and risk of ovarian cancer.

Cancer Causes & Control : CCC
Sarah IrvinNicolas Wentzensen

Abstract

The link between lipid-stabilizing medications and epithelial ovarian carcinogenesis is incompletely understood. Statins may reduce ovarian cancer risk, but results are inconclusive. We conducted a systematic review and meta-analysis of studies reporting associations between statin use and ovarian cancer risk in PubMed. Summary risk ratios (RRs) and confidence intervals (CIs) were calculated. Subgroup analyses by cancer histotype, statin class (lipo- or hydrophilic) and duration of statin use were conducted. Use of individual statins in populations was assessed to determine population-specific differences in statin types. Nine studies with 435,237 total women were included (1 randomized controlled trial (RCT); 4 prospective; 4 case-control). Statin use was associated with a reduced risk of ovarian cancer (RR 0.87, 95% CI 0.74-1.03) and risk was significantly reduced in populations with low pravastatin use (RR 0.83, 95% CI 0.70-0.99). Risk estimates varied by statin class (3 studies; lipophilic: RR 0.88, 95% CI 0.69-1.12; hydrophilic: RR 1.06, 95% CI 0.72-1.57) and cancer histotype (3 studies; serous: RR 0.95, 95% CI 0.69-1.30; clear cell: RR 1.17, 95% CI 0.74-1.86). Long-term use was associated with a reduced risk of ovarian ca...Continue Reading

References

Jan 1, 1987·Epidemiologic Reviews·S Greenland
Sep 2, 1999·Journal of the National Cancer Institute·R B Ness, C Cottreau
Nov 30, 2002·Lancet·James ShepherdUNKNOWN PROSPER study group. PROspective Study of Pravastatin in the Elderly at Risk
Feb 5, 2004·British Journal of Cancer·J A Kaye, H Jick
Aug 17, 2005·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Robin E DuncanMichael C Archer
Dec 13, 2005·Nature Reviews. Drug Discovery·Mukesh K Jain, Paul M Ridker
Dec 13, 2005·Nature Reviews. Cancer·Marie-France DemierreScott M Lippman
Mar 22, 2006·The Oncologist·Katja HindlerCharles D Collard
Oct 19, 2007·Pharmacoepidemiology and Drug Safety·Gary D FriedmanLaurel A Habel
Dec 2, 2008·Cancer Causes & Control : CCC·Onchee YuDiana L Miglioretti
May 29, 2009·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun
Jul 28, 2009·Journal of Clinical Epidemiology·David MoherUNKNOWN PRISMA Group
Jun 7, 2011·JAMA : the Journal of the American Medical Association·Saundra S BuysUNKNOWN PLCO Project Team
Mar 1, 2012·The Lancet Oncology·Celeste Leigh PearceUNKNOWN Ovarian Cancer Association Consortium
Feb 14, 2013·Endocrine-related Cancer·Catherine M OlsenUNKNOWN Ovarian Cancer Association Consortium
Mar 5, 2013·Cancer Causes & Control : CCC·Mette T FaberUNKNOWN Ovarian Cancer Association Consortium
Apr 10, 2013·International Journal of Epidemiology·Weiva SiehUNKNOWN Ovarian Cancer Association Consortium
May 31, 2013·Gynecologic Oncology·Ofer LavieGad Rennert
Dec 4, 2013·Anti-cancer Agents in Medicinal Chemistry·Natalia G VallianouChristos Kazazis
Jan 28, 2014·European Journal of Clinical Pharmacology·Varda ShalevGabriel Chodick
May 28, 2014·Methods in Enzymology·Marco SciacovelliChristian Frezza
Nov 14, 2014·British Journal of Cancer·L BaandrupS K Kjær
Dec 22, 2014·Gynecologic Oncology·Alice W LeeCeleste Leigh Pearce
Jul 16, 2015·Lipids in Health and Disease·Yi-Yang LiLi-Mei Fan
Sep 26, 2015·Glycobiology·Beth BinningtonClifford A Lingwood
Jan 14, 2016·Current Molecular Pharmacology·Seyedeh Zahra BathaieFuyuhiko Tamanoi
Jun 22, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nicolas WentzensenShelley S Tworoger
Dec 13, 2016·American Journal of Epidemiology·Christina B RasmussenUNKNOWN , on behalf of the Ovarian Cancer Association Consortium
Jul 13, 2017·Circulation. Cardiovascular Quality and Outcomes·Martin Bødtker MortensenMorten Schmidt
Dec 5, 2017·Cancer Causes & Control : CCC·Geoffrey C KabatThomas E Rohan
Feb 8, 2018·BJOG : an International Journal of Obstetrics and Gynaecology·E UrpilainenM Hinkula
Jul 15, 2018·International Journal of Cancer. Journal International Du Cancer·Babatunde AkinwunmiDaniel W Cramer
Jan 15, 2019·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Jinghua ShiLibo Yang
Apr 13, 2019·Cell Death & Disease·Li GongQiong Duan

❮ Previous
Next ❯

Citations

Feb 20, 2021·Journal of Obstetric, Gynecologic, and Neonatal Nursing : JOGNN·Marit L Bovbjerg

❮ Previous
Next ❯

Software Mentioned

RE

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.